CDK1 and cancer: Here, we show that CDK1, cyclinA2 and cyclinB1 are expressed at increased levels in invasive BC cells in comparison to non-invasive cells, therefore identifying the regulatory mechanisms that control CDK1 and cyclin expression in cancer is paramount.